Free Trial
→ Your free book is about to disappear (From Profits Run) (Ad)tc pixel Free INGN Stock Alerts

Inogen (INGN) Financials

Inogen logo
$5.62 -0.14 (-2.35%)
Closing price 03:59 PM Eastern
Extended Trading
$5.64 +0.02 (+0.36%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Inogen

Annual Income Statements for Inogen

This table shows Inogen's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 12 21 21 409 216 -5.83 -6.33 -84 -102 -36 -23
Consolidated Net Income / (Loss)		 12 21 21 52 21 -5.83 -6.33 -84 -102 -36 -23
Net Income / (Loss) Continuing Operations		 12 21 21 409 217 -5.83 -6.33 -84 -102 -36 -23
Total Pre-Tax Income 		15 23 30 40 24 -5.28 8.66 -83 -102 -36 -23
Total Operating Income		 15 23 28 38 20 -12 9.24 -85 -109 -43 -30
Total Gross Profit		 76 97 121 357 172 138 176 154 127 155 154
Total Revenue		 159 203 249 537 724 308 358 377 316 336 349
Operating Revenue		 159 203 249 537 724 308 358 377 316 336 349
Total Cost of Revenue		 83 106 128 180 208 170 182 224 189 181 194
Operating Cost of Revenue		 83 106 128 180 208 170 182 224 189 181 194
Total Operating Expenses		 61 74 94 -38 304 150 167 239 236 197 184
Selling, General & Admin Expense		 26 32 38 38 37 39 38 44 75 73 67
Marketing Expense		 31 38 51 96 106 98 113 121 107 103 98
Research & Development Expense		 4.18 5.11 5.31 7.03 9.40 14 17 22 21 22 19
Impairment Charge		 - - - - - - 0.00 0.00 33 0.00 0.00
Total Other Income / (Expense), net		 -0.32 -0.14 2.07 2.56 8.97 6.75 -0.58 1.98 7.04 6.04 6.83
Interest & Investment Income		 0.10 0.20 0.77 3.26 4.71 0.91 0.13 2.84 6.57 5.19 4.39
Other Income / (Expense), net		 -0.40 -0.33 1.30 -0.70 4.25 5.84 -0.71 -0.86 0.47 0.85 2.44
Income Tax Expense		 3.14 2.21 8.65 -11 3.32 0.55 15 0.50 0.11 -0.59 -0.63
Basic Earnings per Share		 $0.60 $1.02 $1.02 $2.44 $0.96 ($0.27) ($0.28) ($3.67) ($4.42) ($1.52) ($0.86)
Weighted Average Basic Shares Outstanding		 19.40M 20.07M 20.68M 21.27M 21.82M 21.98M 22.49M 22.85M 23.18M 23.65M 26.60M
Diluted Earnings per Share		 $0.56 $0.97 $0.96 $2.30 $0.94 ($0.27) ($0.28) ($3.67) ($4.42) ($1.52) ($0.86)
Weighted Average Diluted Shares Outstanding		 20.71M 21.10M 21.90M 22.51M 22.24M 21.98M 22.49M 22.85M 23.18M 23.65M 26.60M
Weighted Average Basic & Diluted Shares Outstanding		 19.30M 20.10M 20.60M 21.81M 21.82M 21.98M 22.49M 22.97M 23.33M 26.53M 27.23M

Quarterly Income Statements for Inogen

This table shows Inogen's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -15 -5.59 -5.96 -9.76 -6.17 -4.15 -5.29 -7.13 -8.32 -3.85 -16
Consolidated Net Income / (Loss)		 -15 -5.59 -5.96 -9.76 -6.17 -4.15 -5.29 -7.13 -8.32 -3.85 -16
Net Income / (Loss) Continuing Operations		 -15 -5.59 -5.96 -9.76 -6.17 -4.15 -3.61 -7.13 -8.32 -3.85 -15
Total Pre-Tax Income 		-15 -5.60 -6.06 -10 -6.27 -4.31 -3.76 -7.36 -8.50 -4.00 -15
Total Operating Income		 -16 -7.06 -7.79 -11 -7.66 -6.13 -5.44 -9.31 -9.34 -5.10 -16
Total Gross Profit		 34 43 41 36 36 41 36 35 38 43 34
Total Revenue		 78 89 89 80 82 92 79 82 85 95 77
Operating Revenue		 78 89 89 80 82 92 79 82 85 95 77
Total Cost of Revenue		 44 46 47 44 46 51 43 46 47 52 43
Operating Cost of Revenue		 44 46 47 44 46 51 43 46 47 52 43
Total Operating Expenses		 51 50 49 48 44 47 42 45 47 48 50
Selling, General & Admin Expense		 17 19 19 18 16 17 16 16 17 18 15
Marketing Expense		 27 26 26 24 24 25 21 23 25 25 19
Research & Development Expense		 6.58 5.62 3.52 5.90 4.03 5.21 4.84 5.32 5.10 5.87 5.40
Impairment Charge		 0.00 0.00 0.00 - - - 0.00 - - - 11
Total Other Income / (Expense), net		 1.55 1.47 1.73 1.30 1.39 1.82 1.68 1.94 0.84 1.09 0.97
Interest & Investment Income		 1.40 1.33 1.04 1.41 1.03 1.12 1.07 1.16 0.88 0.86 0.87
Other Income / (Expense), net		 0.14 0.13 0.69 -0.11 0.36 0.70 0.61 0.78 -0.04 0.23 0.10
Income Tax Expense		 -0.15 -0.01 -0.10 -0.33 -0.10 -0.15 -0.15 -0.24 -0.17 -0.15 0.15
Net Income / (Loss) Discontinued Operations		 - - - - - - -1.68 - - - -1.36
Basic Earnings per Share		 ($0.62) ($0.24) ($0.25) ($0.41) ($0.25) ($0.15) ($0.20) ($0.26) ($0.30) ($0.14) ($0.61)
Weighted Average Basic Shares Outstanding		 23.40M 23.61M 23.75M 23.65M 25.16M 26.96M 27.08M 26.60M 27.32M 27.05M 26.46M
Diluted Earnings per Share		 ($0.62) ($0.24) ($0.25) ($0.41) ($0.25) ($0.15) ($0.20) ($0.26) ($0.30) ($0.14) ($0.61)
Weighted Average Diluted Shares Outstanding		 23.40M 23.61M 23.75M 23.65M 25.16M 26.96M 27.08M 26.60M 27.32M 27.05M 26.46M
Weighted Average Basic & Diluted Shares Outstanding		 23.58M 23.72M 23.82M 26.53M 26.89M 27.04M 27.15M 27.23M 27.07M 26.54M 26.00M

Annual Cash Flow Statements for Inogen

This table details how cash moves in and out of Inogen's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 9.27 27 50 54 1.40 14 24 -49 -62 -8.08 -12
Net Cash From Operating Activities		 38 31 60 60 41 37 24 -38 -3.23 5.91 -11
Net Cash From Continuing Operating Activities		 38 31 60 60 41 37 24 -38 -3.23 5.91 -11
Net Income / (Loss) Continuing Operations		 12 21 21 52 21 -5.83 -6.33 -84 -102 -36 -23
Consolidated Net Income / (Loss)		 12 21 21 52 21 -5.83 -6.33 -84 -102 -36 -23
Depreciation Expense		 14 14 12 11 14 19 22 24 18 21 21
Non-Cash Adjustments To Reconcile Net Income		 23 32 33 37 27 25 25 92 67 30 24
Changes in Operating Assets and Liabilities, net		 -10 -35 -5.38 -41 -21 -1.20 -17 -70 14 -9.00 -33
Net Cash From Investing Activities		 -29 -12 -24 -25 -44 -26 -15 -11 -59 -14 -26
Net Cash From Continuing Investing Activities		 -29 -12 -24 -25 -44 -26 -15 -11 -59 -14 -26
Purchase of Property, Plant & Equipment		 -2.21 -1.72 -2.91 -8.04 -3.14 -4.39 -5.48 -3.34 -5.22 -3.36 -2.52
Acquisitions		 -0.05 -0.11 -7.81 -0.35 -71 -0.26 -0.13 0.00 -30 -2.09 0.00
Purchase of Investments		 -37 -33 -47 -76 -59 -23 -9.99 0.00 -27 -33 -30
Sale of Property, Plant & Equipment		 - 0.39 0.18 0.72 0.19 0.16 0.15 0.33 0.20 0.28 0.00
Sale and/or Maturity of Investments		 20 29 37 63 91 15 19 10 24 36 14
Other Investing Activities, net		 -10 -6.19 -4.00 -4.58 -3.12 -13 -18 -18 -21 -12 -7.86
Net Cash From Financing Activities		 0.38 7.71 14 18 4.93 2.07 15 0.38 0.96 0.27 24
Net Cash From Continuing Financing Activities		 0.38 7.71 14 18 4.93 2.07 15 0.38 0.96 0.27 24
Issuance of Common Equity		 0.70 1.06 1.38 2.35 2.75 2.08 1.95 1.69 1.09 0.81 28
Other Financing Activities, net		 -0.03 6.97 13 16 2.18 -0.02 13 -1.31 -0.13 -0.55 -4.00
Effect of Exchange Rate Changes		 - - - - -0.06 - - -0.48 0.07 -0.28 0.85
Cash Income Taxes Paid		 0.02 -0.45 1.27 1.65 0.24 -0.71 1.54 0.50 -0.70 0.38 0.32

Quarterly Cash Flow Statements for Inogen

This table details how cash moves in and out of Inogen's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents		 -18 -5.97 7.80 8.13 5.12 -18 2.80 -2.74 -11 -5.83 -5.87
Net Cash From Operating Activities		 -4.75 6.69 6.99 -3.02 -17 4.35 2.17 -0.94 -6.69 2.95 -4.47
Net Cash From Continuing Operating Activities		 -4.75 6.69 6.99 -3.02 -17 4.35 2.17 -0.94 -6.69 2.95 -9.87
Net Income / (Loss) Continuing Operations		 -15 -5.59 -5.96 -9.76 -6.17 -4.15 -5.29 -7.13 -8.32 -3.85 -13
Consolidated Net Income / (Loss)		 -15 -5.59 -5.96 -9.76 -6.17 -4.15 -5.29 -7.13 -8.32 -3.85 -16
Depreciation Expense		 5.27 5.35 5.31 5.08 5.19 5.22 5.22 5.04 4.90 4.70 -2.99
Non-Cash Adjustments To Reconcile Net Income		 7.45 6.04 7.46 8.85 5.56 6.83 6.43 5.47 5.88 5.41 12
Changes in Operating Assets and Liabilities, net		 -2.89 0.89 0.18 -7.19 -21 -3.54 -4.19 -4.32 -9.15 -3.31 -5.39
Net Cash From Investing Activities		 -13 -12 0.31 12 -2.04 -23 -0.08 -1.52 -1.98 -3.13 2.20
Net Cash From Continuing Investing Activities		 -13 -12 0.31 12 -2.04 -23 -0.08 -1.52 -1.98 -3.13 4.70
Purchase of Property, Plant & Equipment		 -1.31 -0.05 -1.67 -0.33 -0.29 -0.68 -0.57 -0.98 -0.21 -0.71 -0.28
Purchase of Investments		 -12 -20 -0.00 -0.32 0.00 -19 -3.98 -7.15 -5.86 -7.22 -7.80
Sale and/or Maturity of Investments		 3.00 13 5.00 15 0.00 - 6.00 8.00 4.67 6.00 11
Net Cash From Financing Activities		 0.29 -0.20 0.44 -0.26 24 - 0.42 -0.19 -2.12 -5.62 -3.44
Net Cash From Continuing Financing Activities		 0.29 -0.20 0.44 -0.26 24 - 0.42 -0.19 -2.12 -5.62 -3.44
Repurchase of Common Equity		 - - - - 0.00 - - - -1.87 -5.62 -3.75
Issuance of Common Equity		 0.37 - 0.44 - 28 - 0.48 - 0.37 - 0.36
Other Financing Activities, net		 -0.09 -0.20 - -0.26 -3.75 - -0.06 -0.19 -0.62 - -0.05
Effect of Exchange Rate Changes		 -0.14 -0.08 0.06 -0.13 0.00 0.64 0.30 -0.09 0.17 -0.02 -0.15
Cash Income Taxes Paid		 0.42 0.06 -0.14 0.03 0.40 0.08 -0.16 0.00 0.45 0.03 0.02

Annual Balance Sheets for Inogen

This table presents Inogen's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 161 214 275 376 447 462 490 405 326 296 299
Total Current Assets		 115 162 228 315 292 306 329 305 207 185 225
Cash & Equivalents		 66 93 143 197 198 212 236 187 125 114 104
Restricted Cash		 - - - - - - - - 0.00 3.62 1.29
Short-Term Investments		 17 21 31 44 11 19 9.99 0.00 2.98 0.00 16
Accounts Receivable		 20 31 31 37 34 30 24 63 42 30 34
Inventories, net		 8.65 14 19 27 36 25 32 34 22 25 26
Prepaid Expenses		 0.87 1.66 2.58 7.47 10 18 26 19 14 14 11
Current Deferred & Refundable Income Taxes		 2.16 0.43 1.31 2.66 2.98 2.05 1.34 1.63 0.67 0.00 0.00
Other Current Nonoperating Assets		 - - - - - - - - - - 32
Plant, Property, & Equipment, net		 31 25 20 22 19 28 39 43 50 44 10
Total Noncurrent Assets		 16 27 26 39 136 128 121 57 69 66 64
Goodwill		 - - 2.36 2.26 33 33 33 33 10 9.47 11
Intangible Assets		 0.23 0.24 4.72 3.76 78 69 60 0.18 35 30 31
Other Noncurrent Operating Assets		 0.10 0.41 0.77 2.83 11 11 28 24 24 26 23
Total Liabilities & Shareholders' Equity		 161 214 275 376 447 462 490 405 326 296 299
Total Liabilities		 27 32 48 65 103 112 119 108 121 122 106
Total Current Liabilities		 22 23 34 47 50 57 62 65 72 77 64
Accounts Payable		 13 13 21 27 31 34 26 34 30 27 33
Accrued Expenses		 1.23 1.69 2.51 3.55 4.92 5.74 6.48 7.79 9.63 9.74 10
Current Deferred Revenue		 2.32 2.24 3.53 4.45 5.48 6.99 8.57 8.88 7.98 6.65 3.22
Current Deferred & Payable Income Tax Liabilities		 0.01 - 0.35 0.39 0.82 1.24 0.08 0.00 0.03 0.14 0.18
Current Employee Benefit Liabilities		 5.27 6.12 6.88 11 6.22 7.09 17 11 11 17 9.40
Other Current Liabilities		 - - - - 2.01 1.93 3.39 3.52 14 16 3.16
Other Current Nonoperating Liabilities		 - - - - - - - - - - 4.86
Total Noncurrent Liabilities		 5.28 9.12 14 19 53 56 58 42 49 46 43
Noncurrent Deferred Revenue		 4.20 7.04 9.40 12 14 12 12 10 8.23 5.75 3.60
Noncurrent Deferred & Payable Income Tax Liabilities		 - - 0.35 0.23 0.09 0.03 0.00 0.00 8.54 6.95 6.75
Other Noncurrent Operating Liabilities		 1.08 2.07 4.40 6.81 39 44 46 32 32 33 33
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 134 182 227 310 345 350 370 297 205 174 192
Total Preferred & Common Equity		 134 182 227 310 345 350 370 297 205 174 192
Total Common Equity		 134 182 227 310 345 350 370 297 205 174 192
Common Stock		 179 194 218 249 263 274 299 312 321 328 364
Retained Earnings		 -45 -12 8.64 60 81 76 69 -15 -117 -153 -176
Accumulated Other Comprehensive Income / (Loss)		 -0.04 -0.04 0.27 0.72 -0.09 0.48 1.47 -0.24 1.23 -1.50 4.24

Quarterly Balance Sheets for Inogen

This table presents Inogen's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets		 344 316 309 306 308 312 307 286 286 265
Total Current Assets		 225 199 195 193 201 203 204 191 194 208
Cash & Equivalents		 125 107 98 106 119 104 106 93 87 82
Restricted Cash		 - - 3.56 3.59 3.65 1.27 1.28 1.30 1.30 0.87
Short-Term Investments		 13 12 20 15 0.00 19 17 17 18 15
Accounts Receivable		 48 40 36 34 37 39 40 42 46 49
Inventories, net		 24 25 24 23 26 24 25 25 29 29
Prepaid Expenses		 14 14 12 9.78 15 17 14 12 13 12
Current Deferred & Refundable Income Taxes		 0.47 0.98 1.05 0.96 0.00 0.00 0.00 0.00 0.00 0.00
Other Current Nonoperating Assets		 - - - - - - - - - 21
Plant, Property, & Equipment, net		 50 49 47 47 41 40 37 34 32 8.62
Total Noncurrent Assets		 69 67 67 67 67 69 66 62 60 48
Goodwill		 9.87 9.83 9.76 10 9.86 11 11 10 10 0.00
Intangible Assets		 34 33 34 34 32 33 32 29 27 26
Other Noncurrent Operating Assets		 25 24 24 23 25 25 23 22 22 22
Total Liabilities & Shareholders' Equity		 344 316 309 306 308 312 307 286 286 265
Total Liabilities		 113 124 121 121 110 113 110 103 111 108
Total Current Liabilities		 60 74 72 72 65 67 65 61 71 70
Accounts Payable		 30 32 27 27 36 35 34 33 40 41
Accrued Expenses		 9.03 10 9.76 9.49 9.66 9.74 9.79 9.98 10 9.97
Current Deferred Revenue		 8.48 7.42 7.39 6.98 6.41 6.26 5.97 5.09 4.72 4.42
Current Deferred & Payable Income Tax Liabilities		 0.20 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Current Employee Benefit Liabilities		 8.37 11 14 14 11 13 12 10 13 12
Other Current Liabilities		 3.89 14 15 15 2.95 3.08 3.12 3.49 3.25 3.26
Other Current Nonoperating Liabilities		 - - - - - - - - - 0.00
Total Noncurrent Liabilities		 53 50 49 48 45 45 45 42 40 38
Noncurrent Deferred Revenue		 8.88 7.61 7.07 6.44 5.11 4.59 4.08 3.17 2.86 2.59
Noncurrent Deferred & Payable Income Tax Liabilities		 8.42 8.15 8.07 8.38 7.41 7.95 7.89 6.57 6.49 6.45
Other Noncurrent Operating Liabilities		 35 34 34 34 32 33 33 32 31 29
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 231 192 188 185 198 199 197 183 175 157
Total Preferred & Common Equity		 231 192 188 185 198 199 197 183 175 157
Total Common Equity		 231 192 188 185 198 199 197 183 175 157
Common Stock		 322 323 325 327 357 360 362 363 360 358
Retained Earnings		 -90 -132 -137 -143 -159 -163 -168 -184 -188 -204
Accumulated Other Comprehensive Income / (Loss)		 -0.58 0.19 -0.14 1.72 -0.51 2.89 3.68 3.42 3.08 3.02

Annual Metrics And Ratios for Inogen

This table displays calculated financial ratios and metrics derived from Inogen's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 19,652,273.00 20,260,695.00 20,870,357.00 21,522,602.00 21,998,485.00 22,117,647.00 22,724,098.00 22,921,002.00 23,307,814.00 - 27,148,482.00
DEI Adjusted Shares Outstanding		 19,652,273.00 20,260,695.00 20,870,357.00 21,522,602.00 21,998,485.00 22,117,647.00 22,724,098.00 22,921,002.00 23,307,814.00 - 27,148,482.00
DEI Earnings Per Adjusted Shares Outstanding		 0.59 1.01 1.01 19.00 9.80 -0.26 -0.28 -3.65 -4.40 - -0.84
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 41.29% 27.56% 22.98% 115.16% 34.88% -57.38% 16.05% 5.37% -16.32% 6.35% 3.86%
EBITDA Growth		 27.15% 25.94% 14.13% 17.72% -21.89% -67.28% 143.37% -307.54% -45.01% 77.24% 65.61%
EBIT Growth		 40.04% 53.85% 28.21% 28.75% -35.36% -125.74% 237.83% -1,109.44% -26.49% 61.75% 33.37%
NOPAT Growth		 65.88% 74.36% -5.36% 148.53% -64.83% -149.28% 19.72% -782.96% -28.32% 61.13% 28.95%
Net Income Growth		 69.72% 77.12% 2.35% 146.86% -59.59% -127.82% -8.65% -1,222.79% -22.30% 64.97% 36.62%
EPS Growth		 86.67% 73.21% -1.03% 139.58% -59.13% -128.72% -3.70% -1,210.71% -20.44% 65.61% 43.42%
Operating Cash Flow Growth		 143.11% -18.68% 94.93% -0.85% -32.32% -8.82% -36.15% -258.81% 91.38% 282.87% -289.65%
Free Cash Flow Firm Growth		 1,738.21% -82.65% 794.20% -8.84% -253.16% 118.00% -250.11% -247.02% 6.24% 76.80% -265.58%
Invested Capital Growth		 -16.95% 32.60% -22.15% 31.98% 93.40% -12.63% 5.33% -11.48% -30.85% -26.06% 26.43%
Revenue Q/Q Growth		 7.67% 5.41% 5.47% 60.03% 32.06% -56.78% 12.86% 3.20% -3.72% 1.26% 0.47%
EBITDA Q/Q Growth		 8.30% 6.50% -1.18% -2.20% -8.28% -26.09% -2.58% -442.90% 24.00% 45.32% 29.19%
EBIT Q/Q Growth		 15.39% 12.36% -0.92% -2.16% -17.96% -310.96% -16.12% -147.20% 21.31% 29.21% 9.68%
NOPAT Q/Q Growth		 25.48% 8.21% -24.41% 24.40% -39.38% -1.70% -158.89% -155.01% 21.24% 29.27% 6.44%
Net Income Q/Q Growth		 25.30% 7.33% -21.83% 25.86% -35.28% -179.84% -155.44% -67.41% 22.68% 31.88% 10.36%
EPS Q/Q Growth		 19.15% 6.59% -21.31% 25.00% -34.72% -200.00% -158.33% -67.58% 23.13% 32.74% 14.85%
Operating Cash Flow Q/Q Growth		 27.49% -19.20% 14.86% -1.11% -6.77% 22.54% -29.10% -141.33% 79.23% 2.25% 15.61%
Free Cash Flow Firm Q/Q Growth		 91.79% -85.89% 123.90% 5.89% -3.10% 289.82% -462.06% -141.01% 12.52% 7.27% -5.69%
Invested Capital Q/Q Growth		 -8.47% 42.62% -8.76% 3.96% -4.89% -10.29% -14.46% -21.82% -17.55% -7.69% -1.80%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 47.96% 47.98% 48.60% 66.55% 23.74% 44.79% 49.30% 40.70% 40.14% 46.09% 44.24%
EBITDA Margin		 18.02% 17.79% 16.51% 9.04% 5.23% 4.02% 8.42% -16.59% -28.75% -6.15% -2.04%
Operating Margin		 9.47% 11.27% 11.06% 7.06% 2.73% -3.90% 2.58% -22.60% -34.65% -12.66% -8.66%
EBIT Margin		 9.21% 11.11% 11.58% 6.93% 3.32% -2.01% 2.38% -22.82% -34.50% -12.41% -7.96%
Profit (Net Income) Margin		 7.29% 10.12% 8.42% 9.66% 2.89% -1.89% -1.77% -22.21% -32.46% -10.69% -6.52%
Tax Burden Percent		 78.67% 90.29% 70.82% 128.15% 86.31% 110.40% -73.14% 100.61% 100.10% 98.39% 97.30%
Interest Burden Percent		 100.55% 100.84% 102.65% 108.76% 100.95% 85.31% 101.51% 96.71% 93.96% 87.54% 84.21%
Effective Tax Rate		 21.34% 9.71% 29.18% -28.15% 13.69% 0.00% 173.14% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 20.89% 34.51% 32.22% 78.85% 16.62% -6.63% -5.56% -50.76% -82.01% -44.83% -33.09%
ROIC Less NNEP Spread (ROIC-NNEP)		 21.26% 34.64% 31.20% 77.26% 14.89% -7.81% -5.74% -39.62% -65.60% -39.84% -31.74%
Return on Net Nonoperating Assets (RNNOA)		 -11.70% -21.53% -21.95% -59.56% -10.22% 4.95% 3.80% 25.66% 41.21% 25.87% 20.66%
Return on Equity (ROE)		 9.19% 12.98% 10.27% 19.29% 6.40% -1.68% -1.76% -25.10% -40.80% -18.95% -12.43%
Cash Return on Invested Capital (CROIC)		 39.40% 6.48% 57.12% 51.28% -47.05% 6.86% -10.75% -38.58% -45.54% -14.86% -56.44%
Operating Return on Assets (OROA)		 9.72% 12.01% 11.81% 11.43% 5.84% -1.36% 1.79% -19.25% -29.79% -13.39% -9.34%
Return on Assets (ROA)		 7.69% 10.93% 8.59% 15.93% 5.09% -1.28% -1.33% -18.73% -28.02% -11.53% -7.65%
Return on Common Equity (ROCE)		 9.19% 12.98% 10.27% 19.29% 6.40% -1.68% -1.76% -25.10% -40.80% -18.95% -12.43%
Return on Equity Simple (ROE_SIMPLE)		 8.64% 11.27% 9.25% 16.70% 6.08% -1.67% -1.71% -28.17% 0.00% -20.64% 0.00%
Net Operating Profit after Tax (NOPAT)		 12 21 20 49 17 -8.42 -6.76 -60 -77 -30 -21
NOPAT Margin		 7.45% 10.18% 7.83% 9.05% 2.36% -2.73% -1.89% -15.82% -24.26% -8.87% -6.06%
Net Nonoperating Expense Percent (NNEP)		 -0.37% -0.13% 1.02% 1.59% 1.72% 1.18% 0.18% -11.14% -16.41% -4.98% -1.34%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -20.06% -37.39% -17.12% -11.00%
Cost of Revenue to Revenue		 52.04% 52.02% 51.40% 33.45% 28.78% 55.21% 50.70% 59.30% 59.86% 53.91% 55.76%
SG&A Expenses to Revenue		 16.14% 15.67% 15.06% 7.08% 5.13% 12.51% 10.57% 11.64% 23.84% 21.62% 19.33%
R&D to Revenue		 2.63% 2.52% 2.13% 1.31% 1.30% 4.56% 4.63% 5.82% 6.60% 6.44% 5.56%
Operating Expenses to Revenue		 38.49% 36.70% 37.54% -7.06% 42.02% 48.69% 46.72% 63.30% 74.79% 58.76% 52.91%
Earnings before Interest and Taxes (EBIT)		 15 23 29 37 24 -6.19 8.53 -86 -109 -42 -28
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 29 36 41 48 38 12 30 -63 -91 -21 -7.11
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.88 7.47 10.95 8.61 4.36 2.83 2.09 1.52 0.62 1.26 0.95
Price to Tangible Book Value (P/TBV)		 5.89 7.48 11.30 8.78 6.42 3.99 2.79 1.71 0.80 1.63 1.21
Price to Revenue (P/Rev)		 4.95 6.71 9.96 4.98 2.08 3.20 2.16 1.20 0.41 0.65 0.52
Price to Earnings (P/E)		 68.01 66.32 118.33 6.53 6.97 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 1.47% 1.51% 0.85% 15.30% 14.34% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 13.71 18.28 43.53 34.71 9.55 6.39 4.23 2.40 0.00 1.79 0.86
Enterprise Value to Revenue (EV/Rev)		 4.44 6.15 9.27 4.53 1.79 2.45 1.47 0.70 0.00 0.30 0.18
Enterprise Value to EBITDA (EV/EBITDA)		 24.61 34.55 56.11 50.16 34.16 61.09 17.48 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 48.15 55.34 80.00 65.39 53.82 0.00 61.79 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 59.57 60.40 118.29 50.08 75.76 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 18.48 40.18 38.21 40.55 31.88 20.45 22.30 0.00 0.00 17.08 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 31.58 321.85 66.71 77.01 0.00 86.96 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.55 -0.62 -0.70 -0.77 -0.69 -0.63 -0.66 -0.65 -0.63 -0.65 -0.65
Leverage Ratio		 1.20 1.19 1.20 1.21 1.26 1.31 1.32 1.34 1.46 1.64 1.62
Compound Leverage Factor		 1.20 1.20 1.23 1.32 1.27 1.12 1.34 1.30 1.37 1.44 1.37
Debt to Total Capital		 0.23% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.23% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 99.77% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 -2.88 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 -6.98 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 18.90 27.54 33.19 27.33 11.48 6.78 5.53 3.41 0.49 1.46 1.61
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 5.22 7.07 6.74 6.75 5.82 5.39 5.35 4.66 2.86 2.42 3.12
Quick Ratio		 4.67 6.33 6.06 5.95 4.85 4.60 4.39 3.82 2.35 1.87 2.49
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 22 3.87 35 32 -48 8.71 -13 -45 -43 -9.87 -36
Operating Cash Flow to CapEx		 1,728.31% 2,333.38% 2,215.09% 818.46% 1,376.50% 876.67% 443.48% -1,248.57% -64.42% 191.70% -444.55%
Free Cash Flow to Firm to Interest Expense		 1,015.18 645.75 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 1,734.59 5,172.33 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 1,634.23 4,950.67 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.06 1.08 1.02 1.65 1.76 0.68 0.75 0.84 0.86 1.08 1.17
Accounts Receivable Turnover		 8.11 8.00 8.01 15.67 20.29 9.63 13.22 8.65 6.01 9.35 10.19
Inventory Turnover		 10.18 9.18 7.73 7.82 6.64 5.63 6.40 6.78 6.76 7.76 7.66
Fixed Asset Turnover		 5.08 7.26 11.01 25.29 34.65 12.94 10.66 9.18 6.75 7.09 8.63
Accounts Payable Turnover		 6.86 8.22 7.67 7.57 7.24 5.29 6.11 7.50 5.89 6.32 6.36
Days Sales Outstanding (DSO)		 45.02 45.62 45.56 23.29 17.99 37.89 27.61 42.17 60.69 39.04 35.82
Days Inventory Outstanding (DIO)		 35.87 39.76 47.24 46.67 54.96 64.81 56.99 53.81 54.02 47.05 47.67
Days Payable Outstanding (DPO)		 53.24 44.38 47.58 48.20 50.39 69.06 59.72 48.67 61.92 57.78 57.35
Cash Conversion Cycle (CCC)		 27.65 41.00 45.23 21.76 22.56 33.64 24.89 47.32 52.78 28.30 26.13
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 51 68 53 70 136 118 125 110 76 56 71
Invested Capital Turnover		 2.81 3.39 4.11 8.71 7.04 2.43 2.95 3.21 3.38 5.06 5.46
Increase / (Decrease) in Invested Capital		 -10 17 -15 17 65 -17 6.31 -14 -34 -20 15
Enterprise Value (EV)		 705 1,247 2,311 2,432 1,294 757 527 265 -0.51 101 62
Market Capitalization		 788 1,361 2,485 2,672 1,503 988 773 452 128 218 182
Book Value per Share		 $6.82 $8.99 $10.88 $14.42 $15.67 $15.81 $16.29 $12.98 $8.79 $7.30 $7.08
Tangible Book Value per Share		 $6.81 $8.98 $10.54 $14.14 $10.64 $11.20 $12.19 $11.53 $6.87 $5.62 $5.55
Total Capital		 134 182 227 310 345 350 370 297 205 174 192
Total Debt		 0.32 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -83 -114 -174 -240 -209 -231 -246 -187 -128 -117 -121
Capital Expenditures (CapEx)		 2.21 1.33 2.73 7.33 2.95 4.22 5.33 3.01 5.02 3.09 2.52
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 10 25 21 28 33 18 22 52 6.10 -8.65 14
Debt-free Net Working Capital (DFNWC)		 93 139 195 268 242 249 268 239 135 109 135
Net Working Capital (NWC)		 93 139 195 268 242 249 268 239 135 109 135
Net Nonoperating Expense (NNE)		 0.25 0.13 -1.46 -3.28 -3.87 -2.59 -0.42 24 26 6.13 1.60
Net Nonoperating Obligations (NNO)		 -83 -114 -174 -240 -209 -231 -246 -187 -128 -117 -121
Total Depreciation and Amortization (D&A)		 14 14 12 11 14 19 22 24 18 21 21
Debt-free, Cash-free Net Working Capital to Revenue		 6.44% 12.23% 8.28% 5.15% 4.55% 5.76% 6.19% 13.86% 1.93% -2.58% 3.99%
Debt-free Net Working Capital to Revenue		 58.58% 68.38% 78.02% 49.94% 33.44% 80.71% 74.77% 63.43% 42.63% 32.40% 38.65%
Net Working Capital to Revenue		 58.38% 68.38% 78.02% 49.94% 33.44% 80.71% 74.77% 63.43% 42.63% 32.40% 38.65%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.60 $1.02 $1.02 $2.44 $0.96 ($0.27) ($0.28) ($3.67) ($4.42) ($1.52) ($0.86)
Adjusted Weighted Average Basic Shares Outstanding		 19.40M 20.07M 20.68M 21.27M 21.82M 21.98M 22.49M 22.85M 23.18M 23.65M 26.60M
Adjusted Diluted Earnings per Share		 $0.56 $0.97 $0.96 $2.30 $0.94 ($0.27) ($0.28) ($3.67) ($4.42) ($1.52) ($0.86)
Adjusted Weighted Average Diluted Shares Outstanding		 20.71M 21.10M 21.90M 22.51M 22.24M 21.98M 22.49M 22.85M 23.18M 23.65M 26.60M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 19.85M 20.48M 21.10M 21.81M 22.03M 22.25M 22.49M 22.97M 23.33M 26.53M 27.23M
Normalized Net Operating Profit after Tax (NOPAT)		 12 21 20 27 17 -8.42 6.47 -23 -54 -30 -21
Normalized NOPAT Margin		 7.45% 10.18% 7.83% 4.94% 2.36% -2.73% 1.81% -6.14% -16.96% -8.87% -6.06%
Pre Tax Income Margin		 9.26% 11.20% 11.89% 7.54% 3.35% -1.71% 2.42% -22.07% -32.42% -10.87% -6.71%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 665.77 3,755.83 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 538.18 3,440.75 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 565.41 3,534.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 437.81 3,219.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Inogen

This table displays calculated financial ratios and metrics derived from Inogen's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding		 23,326,783.00 23,577,109.00 23,719,012.00 - 26,529,544.00 26,887,242.00 27,040,390.00 27,148,482.00 27,232,350.00 27,074,516.00 26,538,337.00
DEI Adjusted Shares Outstanding		 23,326,783.00 23,577,109.00 23,719,012.00 - 26,529,544.00 26,887,242.00 27,040,390.00 27,148,482.00 27,232,350.00 27,074,516.00 26,538,337.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.62 -0.24 -0.25 - -0.23 -0.15 -0.20 -0.26 -0.31 -0.14 -0.61
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 8.12% 6.13% 5.80% 5.51% 5.45% 3.96% 4.00% 2.05% 3.44% 3.04% -2.40%
EBITDA Growth		 38.23% 77.75% 95.79% 72.73% 80.57% 86.62% 27.92% 45.62% -111.94% 20.75% -114.17%
EBIT Growth		 25.59% 39.38% 84.92% 59.92% 54.75% 21.67% 8.37% 25.86% -28.47% 10.37% -220.56%
NOPAT Growth		 25.74% 39.97% 83.32% 60.71% 52.96% 13.24% 8.68% 18.27% -21.94% 16.85% -186.73%
Net Income Growth		 28.36% 43.11% 86.96% 63.26% 57.65% 25.72% 11.22% 26.96% -34.82% 7.27% -205.16%
EPS Growth		 29.55% 42.86% 87.31% 64.35% 59.68% 37.50% 20.00% 36.59% -20.00% 6.67% -205.00%
Operating Cash Flow Growth		 24.63% 65.98% 220.00% 4.13% -253.55% -34.97% -69.01% 68.75% 60.18% -32.28% -306.28%
Free Cash Flow Firm Growth		 119.04% 66.32% 63.28% -13.35% -137.33% -141.18% -163.51% -279.73% 70.49% 130.59% 250.45%
Invested Capital Growth		 -32.45% -36.59% -33.96% -26.06% 4.61% 14.23% 18.84% 26.43% -5.27% -10.25% -46.74%
Revenue Q/Q Growth		 2.81% 13.76% 0.08% -9.85% 2.75% 12.15% 0.12% -11.55% 4.15% 11.72% -18.82%
EBITDA Q/Q Growth		 53.85% 85.41% -13.00% -258.46% 67.12% 89.96% -508.96% -170.41% -28.16% 96.25% -10,895.24%
EBIT Q/Q Growth		 43.77% 57.04% -2.53% -61.86% 36.52% 25.64% -19.93% -30.97% -9.99% 48.12% -218.19%
NOPAT Q/Q Growth		 43.85% 56.59% -10.31% -46.12% 32.76% 19.95% -16.10% -30.78% -0.32% 45.42% -205.81%
Net Income Q/Q Growth		 45.10% 61.65% -6.67% -63.63% 36.72% 32.75% -27.50% -34.62% -16.80% 53.75% -319.61%
EPS Q/Q Growth		 46.09% 61.29% -4.17% -64.00% 39.02% 40.00% -33.33% -30.00% -15.38% 53.33% -335.71%
Operating Cash Flow Q/Q Growth		 -50.86% 240.85% 4.53% -143.16% -456.33% 125.91% -50.18% -143.52% -608.91% 144.07% -251.73%
Free Cash Flow Firm Q/Q Growth		 68.90% 43.41% -22.06% -54.11% -172.78% -58.20% -20.19% -29.89% 88.05% 263.98% 449.01%
Invested Capital Q/Q Growth		 -5.56% -7.97% -7.84% -7.69% 33.60% 0.50% -4.11% -1.80% 0.10% -4.78% -43.10%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 44.05% 48.15% 46.54% 45.32% 44.21% 44.80% 44.72% 43.12% 44.49% 45.51% 44.06%
EBITDA Margin		 -13.93% -1.79% -2.02% -8.02% -2.57% -0.23% -1.40% -4.27% -5.26% -0.18% -23.93%
Operating Margin		 -20.86% -7.96% -8.77% -14.22% -9.30% -6.64% -7.70% -11.39% -10.97% -5.36% -20.19%
EBIT Margin		 -20.67% -7.81% -8.00% -14.36% -8.87% -5.88% -7.05% -10.43% -11.02% -5.12% -20.05%
Profit (Net Income) Margin		 -18.68% -6.30% -6.71% -12.18% -7.50% -4.50% -5.73% -8.72% -9.78% -4.05% -20.93%
Tax Burden Percent		 98.98% 99.87% 98.33% 96.73% 98.45% 96.45% 97.32% 96.79% 97.95% 96.15% 110.34%
Interest Burden Percent		 91.30% 80.76% 85.35% 87.71% 85.90% 79.31% 83.56% 86.36% 90.62% 82.30% 94.58%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -52.50% -21.29% -26.48% -50.32% -30.02% -22.47% -27.96% -43.49% -36.76% -18.49% -89.43%
ROIC Less NNEP Spread (ROIC-NNEP)		 -50.34% -20.84% -26.09% -48.87% -29.35% -22.58% -27.71% -42.98% -35.23% -18.24% -85.11%
Return on Net Nonoperating Assets (RNNOA)		 31.31% 13.13% 16.45% 31.73% 18.25% 14.29% 18.02% 27.97% 21.65% 11.23% 58.34%
Return on Equity (ROE)		 -21.19% -8.15% -10.03% -18.59% -11.78% -8.18% -9.94% -15.52% -15.11% -7.25% -31.09%
Cash Return on Invested Capital (CROIC)		 -42.48% -36.31% -13.84% -14.86% -36.67% -45.75% -51.00% -56.44% -24.99% -19.23% 9.45%
Operating Return on Assets (OROA)		 -18.96% -7.46% -8.16% -15.49% -9.67% -6.51% -7.98% -12.23% -13.03% -6.07% -24.71%
Return on Assets (ROA)		 -17.13% -6.02% -6.85% -13.14% -8.18% -4.98% -6.49% -10.22% -11.57% -4.80% -25.79%
Return on Common Equity (ROCE)		 -21.19% -8.15% -10.03% -18.59% -11.78% -8.18% -9.94% -15.52% -15.11% -7.25% -31.09%
Return on Equity Simple (ROE_SIMPLE)		 -50.38% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -11 -4.94 -5.45 -7.97 -5.36 -4.29 -4.98 -6.51 -6.54 -3.57 -11
NOPAT Margin		 -14.60% -5.57% -6.14% -9.95% -6.51% -4.65% -5.39% -7.97% -7.68% -3.75% -14.13%
Net Nonoperating Expense Percent (NNEP)		 -2.16% -0.44% -0.39% -1.45% -0.67% 0.11% -0.25% -0.51% -1.53% -0.25% -4.32%
Return On Investment Capital (ROIC_SIMPLE)		 -5.94% -2.64% -2.94% -4.58% -2.71% -2.15% -2.53% -3.39% -3.57% -2.04% -6.95%
Cost of Revenue to Revenue		 55.95% 51.85% 53.46% 54.68% 55.79% 55.20% 55.28% 56.88% 55.51% 54.49% 55.94%
SG&A Expenses to Revenue		 21.96% 20.92% 21.68% 22.01% 19.73% 18.28% 19.65% 19.73% 20.56% 18.59% 19.10%
R&D to Revenue		 8.43% 6.33% 3.96% 7.37% 4.90% 5.65% 5.24% 6.51% 5.99% 6.17% 7.00%
Operating Expenses to Revenue		 64.91% 56.10% 55.31% 59.53% 53.51% 51.44% 52.42% 54.51% 55.46% 50.87% 64.24%
Earnings before Interest and Taxes (EBIT)		 -16 -6.93 -7.11 -12 -7.30 -5.43 -6.51 -8.53 -9.38 -4.87 -15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -11 -1.59 -1.79 -6.42 -2.11 -0.21 -1.29 -3.49 -4.47 -0.17 -18
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.98 1.02 1.24 1.26 0.96 0.95 1.12 0.95 0.92 1.00 0.89
Price to Tangible Book Value (P/TBV)		 1.26 1.33 1.63 1.63 1.21 1.22 1.43 1.21 1.17 1.27 1.07
Price to Revenue (P/Rev)		 0.59 0.59 0.69 0.65 0.56 0.55 0.64 0.52 0.48 0.49 0.40
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.95 1.06 1.73 1.79 0.88 0.86 1.33 0.86 0.80 1.00 1.09
Enterprise Value to Revenue (EV/Rev)		 0.21 0.22 0.32 0.30 0.20 0.19 0.28 0.18 0.16 0.19 0.12
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 72.09 18.30 17.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.01
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.62 -0.63 -0.63 -0.65 -0.62 -0.63 -0.65 -0.65 -0.61 -0.62 -0.69
Leverage Ratio		 1.48 1.48 1.56 1.64 1.60 1.60 1.60 1.62 1.56 1.60 1.61
Compound Leverage Factor		 1.35 1.19 1.33 1.44 1.38 1.27 1.34 1.40 1.41 1.31 1.53
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 1.66 1.79 1.97 1.79 1.86 1.84 2.04 1.82 1.74 1.73 1.46
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.70 2.70 2.66 2.42 3.07 3.03 3.14 3.12 3.10 2.74 2.96
Quick Ratio		 2.17 2.13 2.14 1.87 2.38 2.40 2.52 2.49 2.47 2.14 2.07
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 23 33 26 12 -8.68 -14 -17 -21 -2.56 4.20 23
Operating Cash Flow to CapEx		 -382.98% 74,322.22% 463.05% -925.77% -5,750.00% 635.96% 381.51% -96.32% -3,183.33% 414.35% -1,596.43%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.92 0.96 1.02 1.08 1.09 1.11 1.13 1.17 1.18 1.19 1.23
Accounts Receivable Turnover		 6.83 7.49 8.03 9.35 8.85 9.20 9.30 10.19 8.96 8.36 7.92
Inventory Turnover		 6.03 6.85 7.81 7.76 7.20 7.78 7.92 7.66 7.64 7.43 7.28
Fixed Asset Turnover		 6.75 6.79 6.90 7.09 7.52 7.88 8.27 8.63 9.40 9.85 15.34
Accounts Payable Turnover		 5.98 6.90 6.44 6.32 5.42 6.08 6.26 6.36 5.71 5.26 5.26
Days Sales Outstanding (DSO)		 53.42 48.70 45.48 39.04 41.25 39.65 39.24 35.82 40.76 43.65 46.08
Days Inventory Outstanding (DIO)		 60.54 53.30 46.72 47.05 50.67 46.91 46.07 47.67 47.80 49.14 50.16
Days Payable Outstanding (DPO)		 60.99 52.91 56.69 57.78 67.37 60.08 58.29 57.35 63.98 69.45 69.42
Cash Conversion Cycle (CCC)		 52.97 49.09 35.50 28.30 24.56 26.49 27.01 26.13 24.58 23.35 26.82
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 72 66 61 56 75 76 73 71 71 68 39
Invested Capital Turnover		 3.60 3.82 4.31 5.06 4.61 4.83 5.19 5.46 4.79 4.93 6.33
Increase / (Decrease) in Invested Capital		 -35 -38 -31 -20 3.32 9.44 12 15 -3.97 -7.77 -34
Enterprise Value (EV)		 68 70 106 101 67 65 96 62 57 68 42
Market Capitalization		 188 192 230 218 189 189 221 182 168 175 140
Book Value per Share		 $8.23 $7.96 $7.82 $7.30 $7.46 $7.42 $7.29 $7.08 $6.72 $6.46 $5.92
Tangible Book Value per Share		 $6.39 $6.12 $5.96 $5.62 $5.90 $5.78 $5.71 $5.55 $5.27 $5.06 $4.93
Total Capital		 192 188 185 174 198 199 197 192 183 175 157
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -120 -121 -124 -117 -123 -124 -125 -121 -111 -107 -98
Capital Expenditures (CapEx)		 1.24 0.01 1.51 0.33 0.29 0.68 0.57 0.98 0.21 0.71 0.28
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 5.48 1.36 -4.10 -8.65 13 12 14 14 18 16 40
Debt-free Net Working Capital (DFNWC)		 125 123 120 109 135 136 139 135 129 123 138
Net Working Capital (NWC)		 125 123 120 109 135 136 139 135 129 123 138
Net Nonoperating Expense (NNE)		 3.19 0.65 0.51 1.79 0.81 -0.14 0.31 0.61 1.79 0.28 5.25
Net Nonoperating Obligations (NNO)		 -120 -121 -124 -117 -123 -124 -125 -121 -111 -107 -118
Total Depreciation and Amortization (D&A)		 5.27 5.35 5.31 5.08 5.19 5.22 5.22 5.04 4.90 4.70 -2.99
Debt-free, Cash-free Net Working Capital to Revenue		 1.70% 0.42% -1.24% -2.58% 3.74% 3.60% 4.11% 3.99% 5.05% 4.64% 11.45%
Debt-free Net Working Capital to Revenue		 38.97% 37.53% 36.24% 32.40% 39.79% 39.61% 39.99% 38.65% 36.76% 34.79% 39.18%
Net Working Capital to Revenue		 38.97% 37.53% 36.24% 32.40% 39.79% 39.61% 39.99% 38.65% 36.76% 34.79% 39.18%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.62) ($0.24) ($0.25) ($0.41) ($0.25) ($0.15) ($0.20) ($0.26) ($0.30) ($0.14) ($0.61)
Adjusted Weighted Average Basic Shares Outstanding		 23.40M 23.61M 23.75M 23.65M 25.16M 26.96M 27.08M 26.60M 27.32M 27.05M 26.46M
Adjusted Diluted Earnings per Share		 ($0.62) ($0.24) ($0.25) ($0.41) ($0.25) ($0.15) ($0.20) ($0.26) ($0.30) ($0.14) ($0.61)
Adjusted Weighted Average Diluted Shares Outstanding		 23.40M 23.61M 23.75M 23.65M 25.16M 26.96M 27.08M 26.60M 27.32M 27.05M 26.46M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 23.58M 23.72M 23.82M 26.53M 26.89M 27.04M 27.15M 27.23M 27.07M 26.54M 26.00M
Normalized Net Operating Profit after Tax (NOPAT)		 -11 -4.94 -5.45 -7.97 -5.36 -4.29 -4.98 -6.51 -6.54 -3.57 -3.52
Normalized NOPAT Margin		 -14.60% -5.57% -6.14% -9.95% -6.51% -4.65% -5.39% -7.97% -7.68% -3.75% -4.56%
Pre Tax Income Margin		 -18.88% -6.31% -6.83% -12.60% -7.62% -4.67% -5.89% -9.01% -9.98% -4.21% -18.97%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Inogen’s Q2 2026 results showed meaningful sequential improvement, although the company remained unprofitable. Revenue increased to $95.1 million from $85.1 million in Q1 2026 and $92.3 million in Q2 2025. Gross profit rose to $43.3 million, lifting the gross margin to approximately 45.5% from 44.5% in the prior quarter. The operating loss narrowed to $5.1 million from $9.3 million in Q1, while the net loss improved to $3.9 million, or $0.14 per diluted share, compared with $8.3 million, or $0.30 per share, in Q1.

Cash generation also improved in the latest quarter. Operating activities produced $2.9 million of cash in Q2 2026, reversing the $6.7 million operating cash outflow in Q1. However, investing activity and share repurchases more than offset that inflow. The company reported a $5.8 million decrease in cash and equivalents during the quarter, including $5.6 million of common-stock repurchases and $3.1 million of net investing outflows.

Over the available period, revenue has generally trended higher from $75.9 million in Q4 2023 to $95.1 million in Q2 2026, while quarterly losses have narrowed substantially from $26.6 million to $3.9 million. Still, Inogen has not yet reached profitability, and its balance sheet has weakened compared with 2024 and early 2025. Q2 2026 total assets were $285.6 million, down from $312.0 million in Q2 2025, while shareholders’ equity declined to $174.9 million from $199.5 million. The figures include restated historical results, so investors should focus on the latest reported trend rather than making direct comparisons with unrevised filings.

  • Revenue momentum improved: Q2 2026 revenue rose approximately 11.7% sequentially and 3.0% year over year, reaching the highest level among the listed quarterly results.
  • Gross margin strengthened: Gross margin expanded to approximately 45.5%, supported by gross profit growth that outpaced revenue growth from Q1 2026.
  • Operating losses narrowed: The operating loss improved to $5.1 million in Q2 from $9.3 million in Q1 and $6.1 million in Q2 2025.
  • Operating cash flow returned to positive territory: Inogen generated $2.9 million from operations in Q2 2026 after using $6.7 million in Q1.
  • Liquidity remains substantial: Cash, restricted cash and short-term investments totaled approximately $106.9 million at June 30, 2026, while current assets were $194.1 million versus $70.9 million of current liabilities.
  • Investment activity is volatile: The company continues to purchase and mature short-term investments, producing large quarter-to-quarter swings in investing cash flow that may not reflect changes in core operating performance.
  • Share count has been relatively stable: Q2 2026 basic weighted-average shares outstanding were 27.0 million, slightly above the 27.0 million reported in Q2 2025, despite recent repurchases.
  • Profitability remains unresolved: Inogen posted a net loss for every listed quarter, and retained earnings declined to a deficit of $187.8 million at June 30, 2026.
  • Cash reserves are declining: Cash and equivalents fell from $118.9 million in Q1 2025 to $87.3 million in Q2 2026, while the company reported a $5.8 million quarterly decrease in cash.
  • Share repurchases are consuming capital: Inogen repurchased $5.6 million of stock in Q2 2026 despite continuing net losses and a history of negative operating cash flow in several recent quarters.
11/12/26 04:10 PM ETAI Generated. May Contain Errors.

Inogen Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Inogen's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Inogen's net income appears to be on a downward trend, with a most recent value of -$22.75 million in 2025, compared with $11.59 million in 2015. The previous period was -$35.89 million in 2024. Check out Inogen's forecast to explore projected trends and price targets.

Inogen's total operating income in 2025 was -$30.21 million, based on the following breakdown:
  • Total Gross Profit: $154.27 million
  • Total Operating Expenses: $184.47 million

Over the last 10 years, Inogen's total revenue changed from $159.01 million in 2015 to $348.67 million in 2025, a change of 119.3%.

In the past 12 quarters, Inogen's cash and equivalents has ranged from $81.84 million in Q3 2026 to $124.61 million in Q3 2023, and is currently $81.84 million as of their latest financial filing in Q3 2026.

Inogen had total debt of $0.00 at the end of 2025, compared with none in 2024, and a 100.0% decrease since 2015.

Over the last 10 years, Inogen's book value per share changed from 6.82 in 2015 to 7.08 in 2025, a change of 3.8%.


Related Companies

Financial statements for NASDAQ:INGN last updated on 11/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...
Base Camp Trading | Sponsoredtc pixel
Every Starlink dish pays this stock
There's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...
Behind the Markets | Sponsoredtc pixel
My public warning after 55 years of watching the markets
Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...
Weiss Ratings | Sponsoredtc pixel
Your Social Security check is scheduled for a 22% cut
The U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...
American Alternative | Sponsoredtc pixel
Social Security’s trust fund runs short in 2032. Guess who controls Congress.
Social Security's retirement trust fund is projected to run dry in late 2032, per the 2026 Trustees Report. Af...
Priority Gold | Sponsoredtc pixel
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Many investors are about to lose everything
Twenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a househ...
Porter & Company | Sponsoredtc pixel
This Could Be the Biggest Monetary Shift in 50 Years
The U.S. government still values its gold reserves at $42 an ounce, a price set by Congress in 1973. Gold trad...
Patriot Gold Group | Sponsoredtc pixel